A molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the Clinical Molecular Diagnostic, Industrial and Biothreat markets.


Updates from The Motley Fool

Latest updates on Cepheid from Fool.com.


Stock Performance

CPHD vs. S&P 500 | 2 Year Performance
View Interactive CPHD Charts
Sponsored by

Key Data Points

Primary metrics and data points about Cepheid.
Current Price: $33.10
Prev Close: $32.79
Open: $32.78
Bid: $30.28
Ask: $36.89
Day's Range: $32.49 - $33.25
52wk Range: $25.09 - $56.85
Volume: 608,191
Avg Vol 687,818
Market Cap: $2.39B
P/E (ttm): -42.58
EPS (ttm): -$0.77
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Cepheid.
CAPS Rating 3 out of 5
 
240 Outperform
24 Underperform
CAPS All Stars
 
41 Outperform
4 Underperform

How do you think Cepheid will perform against the market?



You pick for Cepheid is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John L. Bishop, CEO

85% Approve

Based on 32 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Cepheid.

A molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the Clinical Molecular Diagnostic, Industrial and Biothreat markets.

  • Exchange: NASDAQ
  • Sector: Technology
  • Industry: Electronics